18 February 2021
Visiongain has published a new report on Vitamin D Therapy Market Report 2021-2031: Forecasts by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Functional Food & Beverage, Pharma, Feed, and Personal Care), End User (Children, Adult, and Pregnant Women), IU Strength. PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Global Vitamin D therapy market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.
Vitamin D is considered to be a group of fat soluble vitamin that helps in increasing the intestinal absorption of calcium, phosphate and magnesium. The major vitamin D compounds in humans include D3 and vitamin D2. Vitamin D deficiency is one of the common problems among the people due to less exposure to symptoms of Vitamin D deficiency is muscle weakness and bone pain.
Vitamin D helps calcium absorption in the stomach and retains adequate serum calcium and phosphate absorptions to aid normal bone mineralization and to prevent hypocalcemic tetany (involuntary contraction of muscles, leading to cramps and spasms). It is also needed for bone growth and bone remodelling by osteoblasts and osteoclasts [1-3]. Without sufficient vitamin D, bones can become thin, brittle, or deformed.
COVID-19 Impact on Vitamin D therapy Market
The market is growing in this pandemic of COVID19 due to awareness of the healthcare segment among the masses. In this time period many programme are held by certain organisation regarding self-care oh health. People are getting aware of certain health care. Hence this market is expected to grow in future periods.
The global Vitamin D Therapy market is driven by the factors such as increase in the target patient population, rise in awareness about vitamin D deficiency, surge in levels of malnutrition, increase in patient compliance to oral medication, rise in prevalence of deficiency of Vitamin D, aging population, sedentary lifestyles and lack of exposure to sun.
The opportunities of growth for the Vitamin D market are yet to be explored and the countries with high prevalence of undernutrition people can prove to be a growth prospect for the company’s manufacturing Vitamin D drugs and dosages.
The fortification of foods, which are already rich in Vitamin D, are likely to pose a challenge to the growth of Vitamin D therapy Market.
Global Vitamin D Therapy Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. Major players profiled in the report, include: Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd (India).
• In 2018, GlaxoSmithKline PLC completed the acquisition of Novartis’ 36.5% stake in its Consumer Healthcare Joint Venture for USD 13 billion.
• In 2018, GlaxoSmithKline plc and Pfizer Inc. join forces to form a new world-leading consumer healthcare joint venture. The joint venture has played a vital role in the categories of pain relief, respiratory, vitamin and mineral supplements, digestive health, skin health, and therapeutic oral health.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Gene Amplification Technologies market was valued at US$4,587 million in 2022 and is projected to grow at a CAGR of 9.8% during the forecast period 2023-2033.
05 December 2022
The global stem cell technologies and applications market was valued at US$9,247 million in 2021 and is projected to grow at a CAGR of 8.9% during the forecast period 2022-2032.
01 December 2022
The biosimilars and follow-on biologics market is valued at US$19,668.3 million in 2022 and is projected to grow at a CAGR of 31.14% during the forecast period 2023-2033.
01 December 2022
The Medical Imaging market was valued at US$38.6 billion in 2021 and is projected to grow at a CAGR of 5.46% during the forecast period 2022-2032.